Assessment of toxicity and oxidative stress associated with omeprazole in Caenorhabditis elegans
Abstract
Omeprazole is an inhibitor of the proton pump which has been extensively studied presently due to the evidence of a potential toxicity related to the generation of reactive species of oxygen (ROS) to its chronic users. Thus, this study aimed to assess the toxicity and oxidative stress of omeprazole in Caenorhabditis elegans. Survival assays, nematode body length and ROS generation trials were carried out after the exposure of C. elegans to omeprazole. The omeprazole used for the treatment of nematodes was the commercial standard in pellets. The pellets were dissolved in a bicarbonate solution (84 mg mL-1) to a 10 mg mL-1 concentration. The N2 wild strain of C. elegans was kept in NGM medium, incubated at 20°C and supplemented with E. coli OP50 as food source. Nematodes in L1 stage were obtained through synchronization and, afterwards, 1500 nematodes were exposed to 5 concentrations of omeprazole (62.5 μg mL-1, 125 μg mL-1, 250 μg mL-1, 500 μg mL-1, 1 mg mL-1). The generation of ROS was assessed through fluorescence in a 0.05 mM 2’,7’-dichlorofluorescein diacetate (DCF-DA) solution. The exposure of C. elegans to omeprazole reduced size (p < 0.05), survival (p < 0.05) and increased generation of ROS (p < 0.05) in a dose-dependent manner. The lethal dose (DL50) was determined as 968 μg mL-1. Bicarbonate, omeprazole diluent, was tested as control and did not present any significant alteration (p > 0.05). The decrease in survival and body length of nematodes treated with omeprazole and the generation of ROS confirm its toxicity.
Downloads
References
Back, P., Braeckman, B. P., & Matthijssens, F. (2012). ROS in aging Caenorhabditis elegans: damage or signaling? Oxidative Medicine and Cellular Longevity, 2012(608478), 14. https://doi.org/10.1155/2012/608478
Benedetto, A., Au, C., Avila, D. S., Milatovid, D., & Aschner, M. (2010). Extracellular dopamine potentiates mn-induced oxidative stress, lifespan reduction, and dopaminergic neurodegeneration in a BLI-3–dependent manner in Caenorhabditis elegans. PLoS Genetics, 6(8), e1001084. https://doi.org/10.1371/journal.pgen.1001084
Brenner, S. (1974). The genetics of Caenorhabditis elegans. Genetics, 77(1), 71-94. https://doi.org/10.1093/genetics/77.1.71
Brownlee, D. J., & Fairweather, I. (1999). Exploring the neurotransmitter labyrinth in nematodes. Trends in Neurosciences, 22(1), 16-24. https://doi.org/10.1016/s0166-2236(98)01281-8
Charão, M. F., Souto, C., Brucker, N., Barth, A., Jornada, D. J., Fagundez, D., Ávila, D. S., Eifler-Lima, V. L., Guterres, S. S., Pohlmann, A. R., & Garcia, S. L. (2015). Caenorhabditis elegans as an alternative in vivo model to determine oral uptake, nanotoxicity, and efficacy of melatonin-loaded lipid-core nanocapsules on paraquat damage. International Journal of Nanomedicine, 10, 5093-5106. https://doi.orb/10.2147/IJN.S84909
Dries, L. S., Haefliger, R., Seibert, B. S., Lima, A. G., Cardoso, C. O., & Perassolo, M. S. (2022). Cognition, oxidative stress and vitamin B12 levels evaluation on patients under long-term omeprazole use. Journal of Pharmacy and Pharmacology, 74(4), 547-555. https://doi.org/10.1093/jpp/rgab001
Gemelli, T., Andrade, R. B., Castro, A. L., Garcia, L. P., & Funcha, C. (2013). Estresse oxidativo como fator importante na fisiopatologia da Doença de Alzheimer. Revista Brasileira Multidisciplinar, 16(1), 67-78. https://doi.org/10.25061/2527-2675/ReBraM/2013.v16i1.43
Gomm, W., Holt, K. von, Thomé, F., Broich, K., Maier, W., Fink, A., Doblhammer, G., & Haenisch, B. (2016). Association of proton pump inhibitors with risk of dementia: a pharmacoepidemiological claims data analysis. JAMA Neurology, 73(4), 410-416.
Korolkovas, A., & França, F. F. A. C. F. (2006). Dicionário Terapêutico Guanabara. Guanabara Koogan.
Moreno-Arriola, E., Cárdenas-Rodríguez, N., Coballase-Urrutia, E., Pedraza-Chaverri, J., Carmona-Aparício, L., & Ortega-Cuellar, D. (2014). Caenorhabditis elegans: A useful model for studying metabolic disorders in which oxidative stress is a contributing factor. Oxidative Medicine and Cellular Longevity, 2014(705253). https://doi.org/10.1155/2014/705253
Motulsky, H. (1989). GraphPad software - versão 8.0 [software]. https://www.graphpad.com/scientific-software/prism
Naveed, A., Jilani, K., Siddique, A. B., Akbar, M., Riaz, M., Mushtaq, Z., Sikandar, M., Ilyas, S., Bibi, I., Asghar, A., Rasool, G., & Irfan, M. (2020). Induction of erythrocyte shrinkage by omeprazole. Dose-Response, 18(3). https://doi.org/10.1177/155932582094694
Ortiz-Guerrero, G., Amador-Muñoz, D., Calderón-Ospina, C. A., López-Fuentes, D., & Mesa, M. O. N. (2018). Proton pump inhibitors and dementia: physiopathological mechanisms and clinical consequences. Neural Plasticity, 5257285. https://doi.org/10.1155/2018/5257285
Pinto, W. J. (2017). Bioquímica clínica. Guanabara Koogan.
Pizzino, G., Irrera, N., Cucinotta, M., Pallio, G., Mannino, F., Arcoraci, V., Squadrito, F., Altavilla, D., & Bitto, A. (2017). Oxidative stress: harms and benefits for human health. Oxidative Medicine and Cellular Longevity, 8416763. https://doi.org/10.1155/2017/8416763
Rasband, W., Research Services Branch, National Institute of Mental Health. (1997). Versão 1.51k [software].
Bethesda. https://imagej.nih.gov/ij/download.html
Ruszkiewicz, J. A., Pinkas, A., Miah, M. R., Weitz, R. L., Lawes, M. J. A., Adinyemi, A. J., Ijomone, O. M., & Aschner, M. (2018). C. elegans as a model in developmental neurotoxicology. Toxicology and Applied Pharmacology, 354, 126-135. https://doi.org/10.1016/j.taap.2018.03.016.
Salgado, A. L., Palma, A. L. R., Ramos, L. P., Miranda, P. E., Oliveira, F. G., Cortelli, A. F. D., Fernades, W. S., & Lapena, S. A. B. (2019). Uso indiscriminado de inibidores da bomba de prótons em receituários de medicamentos de uso contínuo. Brazilian Journal of Health Review, 2(6), 5883-5897. https://doi.org/10.34119/bjhrv2n6-083
Sies, H. (2020). Oxidative stress: Concept and some practical aspects. Antioxidants, 9(9), 852. https://doi.org/10.3390/antiox9090852
Simonian, N. A., & Coyle, J. T. (1996). Oxidative stress in neurodegenerative diseases. Annual Review of Pharmacology and Toxicology, 36, 83-106. https://doi.org/10.1146/annurev.pa.36.040196.000503
White, J. G., Southgate, E., Thomson, J. N., & Brenner, S. (1986). The structure of the nervous system of the nematode Caenorhabditis elegans. Philosophical Transactions of the Royal Society B Biological Sciences, 314(1165), 1-340. https://doi.org/10.1098/rstb.1986.0056
Wu, T., Xu, H., Liang, X., & Tang, M. (2019). Caenorhabditis elegans as a complete model organism for biosafety assessments of nanoparticles. Chemosphere, 221, 708-726. https://doi.org/10.1016/j.chemosphere.2019.01.021
DECLARATION OF ORIGINALITY AND COPYRIGHTS
I Declare that current article is original and has not been submitted for publication, in part or in whole, to any other national or international journal.
The copyrights belong exclusively to the authors. Published content is licensed under Creative Commons Attribution 4.0 (CC BY 4.0) guidelines, which allows sharing (copy and distribution of the material in any medium or format) and adaptation (remix, transform, and build upon the material) for any purpose, even commercially, under the terms of attribution.
Read this link for further information on how to use CC BY 4.0 properly.